Erythrocin 250mg Tablet contains erythromycin, a macrolide antibiotic effective against a broad spectrum of gram-positive and some gram-negative bacteria. It functions by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit, thereby preventing bacterial growth and replication. Erythrocin is commonly prescribed for respiratory tract infections, skin and soft tissue infections, otitis media, and certain sexually transmitted infections such as chlamydia. It is also utilized in patients allergic to penicillin as an alternative treatment. The recommended dosage and duration of therapy depend on the type and severity of the infection, as well as patient-specific factors including age and renal function. Erythrocin should be administered with caution in individuals with a history of liver disease or cardiac arrhythmias due to potential hepatotoxicity and QT prolongation. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea. Hypersensitivity reactions, though rare, may occur. Concomitant use with drugs metabolized by the cytochrome P450 system requires careful monitoring to avoid drug interactions. Patients should complete the full prescribed course to prevent resistance development. Erythrocin 250mg Tablet is a valuable therapeutic agent in managing bacterial infections when used appropriately under medical supervision.